International Marijuana Business News

Female-focused marijuana company first to offer clones in Canada

Ontario-based Natural MedCo has become the first company in Canada to offer marijuana clones for sale to legal recreational consumers, achieving a first-mover advantage for an untapped and underserved consumer segment. Natural MedCo’s Eve brand – which bills itself as “Canada’s premier cannabis brand for all women” – succeeded in getting its clones to market in […]

Read More

New Zealand legalizes medical cannabis for domestic, export markets

A bill to legalize medical marijuana on Tuesday won the approval of New Zealand’s parliamentarians on its third and final vote, paving the way for companies to manufacture MMJ products for domestic and international markets. The law will come into force the day after it receives Royal Assent – a formality in most Commonwealth countries. […]

Read More

Cannabis shortages plague Canadian retailers; here’s how they’re responding

As the Canadian cannabis industry struggles to provide enough supply to meet exuberant demand since recreational use became legal, private retailers are faced with their own challenge: how to stay in business. Many store owners in Alberta, Manitoba and Newfoundland have closed their doors as they await marijuana shipments, while others are considering different courses […]

Read More

Canopy Growth boosts M&A transparency in wake of Aphria fiasco

Cash-rich Canopy Growth bought global vaporizer leader Storz & Bickel for 220 million Canadian dollars ($160 million) in a bid to improve its portfolio of intellectual property. The all-cash deal is also intended to position Canopy to capitalize on the next wave of federally regulated products in Canada and around the world, the Smiths Falls, Ontario company […]

Read More

WHO postpones recommendation for rescheduling cannabis at UN summit

The World Health Organization (WHO) postponed its much-anticipated recommendations about the international scheduling of cannabis, citing a need for more time to review its findings. The recommendations were expected to be released Dec. 7 at the Commission on Narcotic Drugs (CND) 61st reconvened session in Vienna. Recommendations about several other substances were included in the WHO presentation, but […]

Read More

Marlboro maker, Cronos join forces in exclusive CA$2.4 billion deal to tap global cannabis opportunities

Altria Group, one of the largest tobacco companies in North America, has agreed to invest 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group – the most significant foray by Big Tobacco into the rapidly growing cannabis industry to date.

Altria also agreed to make Cronos its exclusive partner for international cannabis opportunities.

Read More

Key UN summit could lead to international rescheduling of cannabis

A crucial milestone for the global industry could be achieved this week, as the World Health Organization (WHO) presents its findings on cannabis to the Commission on Narcotic Drugs (CND) in Vienna. The CND reconvened its 61st session on Dec. 5. The WHO’s Expert Committee on Drug Dependence (ECDD) held meetings in June and November dedicated to pre-review and review […]

Read More

Regulator warns Canadian marijuana firms against ‘problematic practices’

Canada’s stock market regulator warned publicly traded companies in emerging industries such as cannabis and fintech against “problematic promotional activities” that could artificially increase share prices and put investors at risk. The warning from the Canadian Securities Administrators (CSA) – an umbrella organization for provincial securities regulators – came amid already highly volatile cannabis stock […]

Read More

IGC Resources, Westleaf Cannabis close CA$20M raise, including Tilray investment

Alberta marijuana companies IGC Resources (TSXV: IGC.H) and Westleaf Cannabis closed a brokered private placement of 20 million Canadian dollars ($15 million), including CA$2.9 million from British Columbia-based Tilray. The capital raise was completed in connection with Westleaf’s proposed reverse takeover of IGC, which received conditional approval from the TSX Venture Exchange. The company plans to […]

Read More

Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

The blows to Aphria’s stock continued Wednesday as the Canadian cannabis giant’s share price tumbled in the wake of a scathing short-seller report. Aphria’s stock (Nasdaq: APHA) closed Wednesday at $4.51 – down more than 25% for the day. The company has been on the defensive since Monday, refuting claims lobbed by short sellers Quintessential […]

Read More

Medical cannabis export law passes first vote in Israeli Parliament

A long-awaited bill to permit the export of medical cannabis from Israel passed the first of three crucial votes in the country’s Parliament, potentially setting it up for approval in the first half of 2019, according to experts. The bill was passed in the first reading Monday in the Knesset after a government committee approved […]

Read More